# Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis

> **NCT04595045** · PHASE3 · COMPLETED · sponsor: **Aránzazu Vázquez Doce** · enrollment: 84 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Botulinum toxin type A infiltrations

## Key facts

- **NCT ID:** NCT04595045
- **Lead sponsor:** Aránzazu Vázquez Doce
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-24
- **Primary completion:** 2022-07-28
- **Final completion:** 2022-07-28
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595045, "Botulinum Toxin in Patients With Spastic Lower Limb Paresis Associated With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04595045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*